# Fall Assessment â€“ RRT Protocol with Virtua Voorhees Addenda

**Primary Guideline:** American Geriatrics Society 2023 Updated Beers Criteria and Clinical Practice Guideline for Prevention of Falls in Older Persons
**Official Source:** https://geriatricscareonline.org/ProductAbstract/ags-beers-criteria-update-expert-panel/CL025
**Supporting Guidelines:**
- 2024 NICE Quality Standard for Falls Prevention in Older People
- 2023 WHO Global Report on Falls Prevention in Older Age
- Canadian CT Head Rule (Updated 2023 Validation Studies)

## ENHANCED MERMAID FLOWCHART ALGORITHM

~~~mermaid
graph TD
    A["Fall Event Recognition<br/>RRT Activation"] --> B["Primary Survey<br/>ABCs + C-Spine Precautions"]
    
    B --> C["Immediate Safety<br/>Assessment + Vitals"]
    
    C --> D{"Head Strike<br/>or LOC?"}
    
    D -->|YES| E["Neurologic Assessment<br/>GCS + Pupil Check"]
    D -->|NO| F["Comprehensive<br/>Injury Evaluation"]
    
    E --> G{"Anticoagulation<br/>Status?"}
    F --> H{"Fracture<br/>Suspected?"}
    
    G -->|YES| I["High-Risk Protocol<br/>STAT CT + Reversal Ready"]
    G -->|NO| J{"Canadian CT<br/>Rule Positive?"}
    
    H -->|YES| K["Targeted Imaging<br/>X-rays/CT"]
    H -->|NO| L["Soft Tissue Assessment<br/>Pain Management"]
    
    I --> M["CT Head Results<br/>Interpretation"]
    J -->|YES| N["CT Head Within<br/>2 Hours"]
    J -->|NO| O["Clinical Observation<br/>Serial Neuro Checks"]
    
    K --> P{"Fracture<br/>Confirmed?"}
    L --> Q["Fall Risk Assessment<br/>Morse Scale + Medication Review"]
    
    M --> R{"Intracranial<br/>Hemorrhage?"}
    N --> R
    O --> Q
    
    P -->|YES| S{"Surgical<br/>Intervention Needed?"}
    P -->|NO| T["Conservative Management<br/>PT/OT Evaluation"]
    
    R -->|YES| U["Emergency Reversal<br/>Neurosurgery Consult"]
    R -->|NO| V["24-Hour Observation<br/>Neuro Monitoring"]
    
    S -->|YES| W["Orthopedic Surgery<br/>Operative Planning"]
    S -->|NO| T
    
    Q --> X{"High Fall Risk<br/>Score â‰¥51?"}
    
    U --> Y["ICU Admission<br/>Intensive Monitoring"]
    V --> Z["Telemetry Admission<br/>Q1H Neuro Checks"]
    W --> AA["Post-Op Care<br/>Surgical Unit"]
    T --> BB["Medical Floor<br/>Fall Prevention Protocol"]
    
    X -->|YES| CC["Enhanced Prevention<br/>1:1 Sitter + Interventions"]
    X -->|NO| DD["Standard Prevention<br/>Bed Alarm + Rounding"]
    
    Y --> EE["Neurocritical Care<br/>ICP Monitoring"]
    Z --> FF["Stepdown Care<br/>Rehabilitation Planning"]
    AA --> FF
    BB --> FF
    CC --> FF
    DD --> GG["Discharge Planning<br/>Home Safety Assessment"]
    
    FF --> HH["Disposition<br/>Based on Recovery"]
    GG --> HH
    EE --> HH
    
    style A fill:#ffcccc
    style B fill:#ffe6cc
    style I fill:#ffaaaa
    style U fill:#ff6666
    style Q fill:#ccffcc
    style CC fill:#e6ccff
    style Y fill:#ccffee
~~~

## STREAMLINED DYNAMIC CARD SYSTEM

### Card 0 â€“ Fall Event Recognition & Primary Survey (Node A â†’ B)
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸš¨ FALL EVENT RRT ACTIVATION             â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ ğŸ“Š Recognition criteria:                â”‚
â”‚ â€¢ Witnessed or unwitnessed fall        â”‚
â”‚ â€¢ Found on floor/ground                â”‚
â”‚ â€¢ Patient reports falling              â”‚
â”‚ â€¢ Significant mechanism of injury      â”‚
â”‚                                         â”‚
â”‚ ğŸš¨ Primary survey priorities:           â”‚
â”‚ â€¢ Airway: Patent, protect C-spine      â”‚
â”‚ â€¢ Breathing: Adequate ventilation      â”‚
â”‚ â€¢ Circulation: Perfusion/bleeding      â”‚
â”‚ â€¢ Disability: Neurologic status        â”‚
â”‚                                         â”‚
â”‚ ğŸ›¡ï¸ C-spine precautions:                â”‚
â”‚ â€¢ Manual immobilization until cleared  â”‚
â”‚ â€¢ Avoid movement until assessment      â”‚
â”‚ â€¢ Consider cervical collar if indicated â”‚
â”‚                                         â”‚
â”‚ [Next: Safety assessment â–¶]            â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

### Card 1 â€“ Immediate Safety Assessment (Node C â†’ D)
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ” IMMEDIATE SAFETY & VITAL ASSESSMENT   â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ ğŸ“Š Vital signs assessment:              â”‚
â”‚ â€¢ Blood pressure (orthostatic if able) â”‚
â”‚ â€¢ Heart rate and rhythm                â”‚
â”‚ â€¢ Respiratory rate and pattern         â”‚
â”‚ â€¢ Temperature and oxygen saturation    â”‚
â”‚                                         â”‚
â”‚ ğŸ” Mechanism assessment:                â”‚
â”‚ â€¢ Height of fall                       â”‚
â”‚ â€¢ Surface landed on                    â”‚
â”‚ â€¢ Witnessed vs unwitnessed             â”‚
â”‚ â€¢ Ability to get up independently      â”‚
â”‚                                         â”‚
â”‚ ğŸ“ Initial history (if conscious):      â”‚
â”‚ â€¢ Events leading to fall               â”‚
â”‚ â€¢ Loss of consciousness                â”‚
â”‚ â€¢ Current pain/symptoms                â”‚
â”‚ â€¢ Last clear memory                    â”‚
â”‚                                         â”‚
â”‚ [Next: Head strike assessment â–¶]       â”‚
â”‚                                         â”‚
â”‚ [â—€ Previous: Recognition]              â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

### Card 2A â€“ Neurologic Assessment (Node E â†’ G)
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ§  NEUROLOGIC ASSESSMENT PROTOCOL       â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ ğŸ“Š Glasgow Coma Scale:                  â”‚
â”‚ â€¢ Eye opening (1-4)                    â”‚
â”‚ â€¢ Verbal response (1-5)                â”‚
â”‚ â€¢ Motor response (1-6)                 â”‚
â”‚ â€¢ Total score /15                      â”‚
â”‚                                         â”‚
â”‚ ğŸ‘€ Pupil assessment:                    â”‚
â”‚ â€¢ Size, equality, reactivity           â”‚
â”‚ â€¢ Accommodation response               â”‚
â”‚ â€¢ Extraocular movements                â”‚
â”‚                                         â”‚
â”‚ ğŸ” Neurologic examination:              â”‚
â”‚ â€¢ Mental status and orientation        â”‚
â”‚ â€¢ Cranial nerve assessment             â”‚
â”‚ â€¢ Motor strength and sensation         â”‚
â”‚ â€¢ Cerebellar function                  â”‚
â”‚                                         â”‚
â”‚ [Next: Anticoagulation status â–¶]       â”‚
â”‚                                         â”‚
â”‚ [â—€ Previous: Safety Assessment]        â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

### Card 2B â€“ Injury Evaluation (Node F â†’ H)
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ©¹ COMPREHENSIVE INJURY ASSESSMENT      â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ ğŸ” Head-to-toe examination:             â”‚
â”‚ â€¢ Scalp inspection for lacerations     â”‚
â”‚ â€¢ Facial trauma assessment             â”‚
â”‚ â€¢ Neck pain or tenderness              â”‚
â”‚ â€¢ Chest wall integrity                 â”‚
â”‚                                         â”‚
â”‚ ğŸ¦´ Musculoskeletal assessment:          â”‚
â”‚ â€¢ Hip pain, rotation, shortening       â”‚
â”‚ â€¢ Wrist deformity or tenderness        â”‚
â”‚ â€¢ Spine tenderness or deformity        â”‚
â”‚ â€¢ Extremity pain or swelling           â”‚
â”‚                                         â”‚
â”‚ ğŸ©¸ Skin and soft tissue:                â”‚
â”‚ â€¢ Lacerations requiring repair         â”‚
â”‚ â€¢ Hematomas or contusions              â”‚
â”‚ â€¢ Skin tears (common in elderly)       â”‚
â”‚                                         â”‚
â”‚ [Next: Fracture suspicion â–¶]           â”‚
â”‚                                         â”‚
â”‚ [â—€ Previous: Safety Assessment]        â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

### Card 3A â€“ High-Risk Protocol (Node I â†’ M)
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸš¨ HIGH-RISK ANTICOAGULATED PATIENT     â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ ğŸ©¸ Anticoagulation types:               â”‚
â”‚ â€¢ Warfarin (check recent INR)          â”‚
â”‚ â€¢ DOACs (apixaban, rivaroxaban, etc.)  â”‚
â”‚ â€¢ Heparin products                     â”‚
â”‚ â€¢ Antiplatelet agents                  â”‚
â”‚                                         â”‚
â”‚ ğŸ“¸ Immediate STAT CT head:              â”‚
â”‚ â€¢ Order within 15 minutes              â”‚
â”‚ â€¢ No delay for clinical observation    â”‚
â”‚ â€¢ Include CT angiography if indicated  â”‚
â”‚                                         â”‚
â”‚ ğŸ’Š Prepare reversal agents:             â”‚
â”‚ â€¢ 4-Factor PCC available               â”‚
â”‚ â€¢ Vitamin K drawn up                   â”‚
â”‚ â€¢ Specific antidotes (idarucizumab)    â”‚
â”‚ â€¢ Type and crossmatch blood            â”‚
â”‚                                         â”‚
â”‚ [Next: CT interpretation â–¶]            â”‚
â”‚                                         â”‚
â”‚ [â—€ Previous: Neurologic Assessment]    â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

### Card 3B â€“ Canadian CT Rule Assessment (Node J)
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ‡¨ğŸ‡¦ CANADIAN CT HEAD RULE (2023 UPDATE) â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ ğŸ¯ High-risk criteria (any present):    â”‚
â”‚ â€¢ GCS score <15 at 2h post-injury      â”‚
â”‚ â€¢ Suspected open skull fracture        â”‚
â”‚ â€¢ Signs of basal skull fracture        â”‚
â”‚ â€¢ Vomiting â‰¥2 episodes                 â”‚
â”‚ â€¢ Age â‰¥65 years                        â”‚
â”‚                                         â”‚
â”‚ ğŸŸ¡ Medium-risk criteria:                â”‚
â”‚ â€¢ Amnesia before impact â‰¥30 minutes    â”‚
â”‚ â€¢ Dangerous mechanism of injury        â”‚
â”‚                                         â”‚
â”‚ â“ Any CT rule criteria positive?       â”‚
â”‚                                         â”‚
â”‚ ğŸ”˜ YES â†’ CT head within 2 hours        â”‚
â”‚ ğŸ”˜ NO â†’ Clinical observation protocol  â”‚
â”‚                                         â”‚
â”‚ ğŸ“Š Rule sensitivity: 99.4% for need for neurosurgical interventionâ”‚
â”‚                                         â”‚
â”‚ [â—€ Previous] [Next: Based on Selection â–¶]â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

### Card 4A â€“ Fracture Imaging (Node K â†’ P)
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ“¸ TARGETED FRACTURE IMAGING            â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ ğŸ¦´ High-risk fracture sites:            â”‚
â”‚ â€¢ Hip: Unable to bear weight           â”‚
â”‚ â€¢ Wrist: FOOSH mechanism               â”‚
â”‚ â€¢ Spine: Back pain after fall          â”‚
â”‚ â€¢ Shoulder: Arm pain/deformity         â”‚
â”‚                                         â”‚
â”‚ ğŸ“‹ Imaging priorities:                  â”‚
â”‚ â€¢ X-rays first-line for extremities    â”‚
â”‚ â€¢ CT for spine if neuro symptoms        â”‚
â”‚ â€¢ MRI for occult hip fractures         â”‚
â”‚                                         â”‚
â”‚ ğŸ¯ Clinical decision rules:             â”‚
â”‚ â€¢ Ottawa Ankle Rules                   â”‚
â”‚ â€¢ NEXUS C-spine criteria               â”‚
â”‚ â€¢ Canadian C-spine Rule                â”‚
â”‚                                         â”‚
â”‚ [Next: Fracture confirmation â–¶]        â”‚
â”‚                                         â”‚
â”‚ [â—€ Previous: Injury Evaluation]        â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

### Card 4B â€“ Soft Tissue Management (Node L â†’ Q)
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ©¹ SOFT TISSUE CARE & PAIN MANAGEMENT   â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ ğŸ©¹ Wound care priorities:               â”‚
â”‚ â€¢ Clean lacerations with saline        â”‚
â”‚ â€¢ Apply pressure for bleeding          â”‚
â”‚ â€¢ Assess need for sutures/skin adhesiveâ”‚
â”‚ â€¢ Tetanus status verification          â”‚
â”‚                                         â”‚
â”‚ ğŸ’Š Pain management (2023 guidelines):   â”‚
â”‚ â€¢ Acetaminophen 1000mg q6h (first-line)â”‚
â”‚ â€¢ Topical agents (diclofenac gel)      â”‚
â”‚ â€¢ Tramadol 50mg q6h (caution >75y)     â”‚
â”‚ â€¢ Avoid opioids (â†‘fall risk)           â”‚
â”‚                                         â”‚
â”‚ ğŸ§Š Conservative measures:               â”‚
â”‚ â€¢ Ice application 15-20 minutes        â”‚
â”‚ â€¢ Elevation if possible                â”‚
â”‚ â€¢ Compression for swelling             â”‚
â”‚                                         â”‚
â”‚ [Next: Fall risk assessment â–¶]         â”‚
â”‚                                         â”‚
â”‚ [â—€ Previous: Injury Evaluation]        â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

### Card 5A â€“ ICH Emergency Protocol (Node U â†’ Y)
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸš¨ INTRACRANIAL HEMORRHAGE PROTOCOL     â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ ğŸ’Š Emergency reversal (initiate STAT):  â”‚
â”‚                                         â”‚
â”‚ ğŸ©¸ Warfarin reversal:                   â”‚
â”‚ â€¢ Vitamin K 10mg IV over 10 minutes     â”‚
â”‚ â€¢ 4-Factor PCC 25-50 units/kg          â”‚
â”‚ â€¢ Target INR <1.4 within 30 minutes    â”‚
â”‚                                         â”‚
â”‚ ğŸ’Š DOAC reversal:                       â”‚
â”‚ â€¢ Idarucizumab 5g IV (dabigatran)      â”‚
â”‚ â€¢ Andexanet alfa (Xa inhibitors)       â”‚
â”‚ â€¢ 4-Factor PCC if specific unavailable â”‚
â”‚                                         â”‚
â”‚ ğŸ“ Immediate consultations:             â”‚
â”‚ â€¢ Neurosurgery STAT                    â”‚
â”‚ â€¢ ICU admission                        â”‚
â”‚ â€¢ Pharmacy for reversal guidance       â”‚
â”‚                                         â”‚
â”‚ [Next: ICU intensive monitoring â–¶]     â”‚
â”‚                                         â”‚
â”‚ [â—€ Previous: CT Interpretation]        â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

### Card 5B â€“ 24-Hour Observation (Node V â†’ Z)
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ‘ï¸ 24-HOUR NEURO OBSERVATION PROTOCOL   â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ â±ï¸ Monitoring schedule:                 â”‚
â”‚ â€¢ Q15min Ã— 1h, then Q1h Ã— 4h           â”‚
â”‚ â€¢ Q2h Ã— 8h, then Q4h Ã— 12h             â”‚
â”‚ â€¢ Escalate if any changes               â”‚
â”‚                                         â”‚
â”‚ ğŸ“Š Assessment parameters:               â”‚
â”‚ â€¢ Glasgow Coma Scale                   â”‚
â”‚ â€¢ Pupil size and reactivity            â”‚
â”‚ â€¢ Motor strength                       â”‚
â”‚ â€¢ Vital signs                          â”‚
â”‚                                         â”‚
â”‚ ğŸš¨ Escalation triggers:                 â”‚
â”‚ â€¢ GCS decrease â‰¥2 points               â”‚
â”‚ â€¢ New focal neurologic findings        â”‚
â”‚ â€¢ Severe headache or vomiting          â”‚
â”‚ â€¢ Pupillary changes                    â”‚
â”‚                                         â”‚
â”‚ [Next: Telemetry monitoring â–¶]         â”‚
â”‚                                         â”‚
â”‚ [â—€ Previous: CT Interpretation]        â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

### Card 6A â€“ Surgical Planning (Node W â†’ AA)
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ”ª ORTHOPEDIC SURGICAL INTERVENTION     â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ ğŸ¦´ Common surgical fractures:           â”‚
â”‚ â€¢ Displaced femoral neck fractures     â”‚
â”‚ â€¢ Intertrochanteric hip fractures      â”‚
â”‚ â€¢ Open fractures                       â”‚
â”‚ â€¢ Unstable spine fractures             â”‚
â”‚                                         â”‚
â”‚ â±ï¸ Timing considerations:               â”‚
â”‚ â€¢ Hip fractures: Surgery within 48h    â”‚
â”‚ â€¢ Open fractures: Within 6-8 hours     â”‚
â”‚ â€¢ Optimize medical status first        â”‚
â”‚                                         â”‚
â”‚ ğŸ“‹ Pre-operative optimization:          â”‚
â”‚ â€¢ Cardiology clearance if indicated    â”‚
â”‚ â€¢ Blood type and crossmatch            â”‚
â”‚ â€¢ NPO status                           â”‚
â”‚ â€¢ DVT prophylaxis                      â”‚
â”‚                                         â”‚
â”‚ [Next: Post-operative care â–¶]          â”‚
â”‚                                         â”‚
â”‚ [â—€ Previous: Fracture Confirmation]    â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

### Card 6B â€“ Conservative Fracture Management (Node T â†’ BB)
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ›¡ï¸ CONSERVATIVE FRACTURE MANAGEMENT     â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ ğŸ¯ Non-surgical fractures:              â”‚
â”‚ â€¢ Non-displaced fractures              â”‚
â”‚ â€¢ Minimally displaced fractures        â”‚
â”‚ â€¢ High surgical risk patients          â”‚
â”‚                                         â”‚
â”‚ ğŸ©¹ Conservative treatment:              â”‚
â”‚ â€¢ Immobilization/splinting             â”‚
â”‚ â€¢ Pain management optimization         â”‚
â”‚ â€¢ Early mobilization when appropriate  â”‚
â”‚ â€¢ Weight-bearing restrictions          â”‚
â”‚                                         â”‚
â”‚ ğŸƒ PT/OT evaluation:                    â”‚
â”‚ â€¢ Mobility assessment                  â”‚
â”‚ â€¢ Assistive device training            â”‚
â”‚ â€¢ Home safety evaluation               â”‚
â”‚ â€¢ Fall prevention education            â”‚
â”‚                                         â”‚
â”‚ [Next: Medical floor care â–¶]           â”‚
â”‚                                         â”‚
â”‚ [â—€ Previous: Fracture Confirmation]    â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

### Card 7 â€“ Fall Risk Assessment (Node Q â†’ X)
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ“Š COMPREHENSIVE FALL RISK ASSESSMENT   â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ ğŸ“‹ Morse Fall Scale (updated 2024):     â”‚
â”‚ â€¢ History of falling (25 pts)          â”‚
â”‚ â€¢ Secondary diagnosis (15 pts)          â”‚
â”‚ â€¢ Ambulatory aid (30 pts)              â”‚
â”‚ â€¢ IV/heparin lock (20 pts)             â”‚
â”‚ â€¢ Gait assessment (10-20 pts)          â”‚
â”‚ â€¢ Mental status (15 pts)               â”‚
â”‚                                         â”‚
â”‚ ğŸ’Š High-risk medications review:        â”‚
â”‚ â€¢ Benzodiazepines                      â”‚
â”‚ â€¢ Antipsychotics                       â”‚
â”‚ â€¢ Sedative-hypnotics                   â”‚
â”‚ â€¢ â‰¥4 medications (polypharmacy)        â”‚
â”‚                                         â”‚
â”‚ ğŸ” Additional assessments:              â”‚
â”‚ â€¢ Get-up-and-go test (>12s = high risk)â”‚
â”‚ â€¢ Orthostatic vital signs              â”‚
â”‚ â€¢ Vision screening                     â”‚
â”‚                                         â”‚
â”‚ [Next: Risk level determination â–¶]     â”‚
â”‚                                         â”‚
â”‚ [â—€ Previous: Soft Tissue Care]         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

### Card 8A â€“ Enhanced Prevention Protocol (Node CC â†’ FF)
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ›¡ï¸ ENHANCED FALL PREVENTION (HIGH-RISK) â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ ğŸš¨ High-risk interventions (score â‰¥51): â”‚
â”‚ â€¢ 1:1 sitter or continuous observation â”‚
â”‚ â€¢ Bed alarm activated                  â”‚
â”‚ â€¢ Yellow identification armband        â”‚
â”‚ â€¢ Hourly comfort rounds                â”‚
â”‚                                         â”‚
â”‚ ğŸ¥ Environmental modifications:         â”‚
â”‚ â€¢ Low bed position                     â”‚
â”‚ â€¢ Remove clutter/obstacles             â”‚
â”‚ â€¢ Adequate lighting                    â”‚
â”‚ â€¢ Call light within reach              â”‚
â”‚                                         â”‚
â”‚ ğŸ’Š Medication optimization:             â”‚
â”‚ â€¢ Discontinue high-risk medications    â”‚
â”‚ â€¢ Minimize sedating medications        â”‚
â”‚ â€¢ Optimize timing of diuretics         â”‚
â”‚ â€¢ Review dosing appropriateness        â”‚
â”‚                                         â”‚
â”‚ [Next: Rehabilitation planning â–¶]      â”‚
â”‚                                         â”‚
â”‚ [â—€ Previous: Risk Assessment]          â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

### Card 8B â€“ Standard Prevention Protocol (Node DD â†’ GG)
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ“‹ STANDARD FALL PREVENTION (LOW-RISK)  â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ ğŸ›¡ï¸ Standard interventions:              â”‚
â”‚ â€¢ Bed alarm if indicated               â”‚
â”‚ â€¢ Regular rounding q2h                 â”‚
â”‚ â€¢ Clear pathways                       â”‚
â”‚ â€¢ Proper footwear                      â”‚
â”‚                                         â”‚
â”‚ ğŸ“š Patient education:                   â”‚
â”‚ â€¢ Fall risk awareness                  â”‚
â”‚ â€¢ Call for assistance                  â”‚
â”‚ â€¢ Proper use of assistive devices      â”‚
â”‚ â€¢ Home safety modifications            â”‚
â”‚                                         â”‚
â”‚ ğŸ”„ Reassessment schedule:               â”‚
â”‚ â€¢ Daily during admission               â”‚
â”‚ â€¢ After changes in condition           â”‚
â”‚ â€¢ Prior to discharge                   â”‚
â”‚                                         â”‚
â”‚ [Next: Discharge planning â–¶]           â”‚
â”‚                                         â”‚
â”‚ [â—€ Previous: Risk Assessment]          â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

### Card 9A â€“ Neurocritical Care (Node EE â†’ HH)
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ§  NEUROCRITICAL CARE MANAGEMENT        â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ ğŸ¥ ICU monitoring priorities:           â”‚
â”‚ â€¢ ICP monitoring if indicated          â”‚
â”‚ â€¢ Continuous EEG if seizures           â”‚
â”‚ â€¢ Frequent neurologic assessments      â”‚
â”‚ â€¢ Hemodynamic optimization             â”‚
â”‚                                         â”‚
â”‚ ğŸ“Š Advanced monitoring:                 â”‚
â”‚ â€¢ Arterial line for blood pressure     â”‚
â”‚ â€¢ Central venous access                â”‚
â”‚ â€¢ Foley catheter for accurate I/O      â”‚
â”‚                                         â”‚
â”‚ ğŸ¯ Treatment goals:                     â”‚
â”‚ â€¢ Prevent secondary brain injury       â”‚
â”‚ â€¢ Optimize cerebral perfusion          â”‚
â”‚ â€¢ Manage complications                 â”‚
â”‚                                         â”‚
â”‚ [Next: Disposition planning â–¶]         â”‚
â”‚                                         â”‚
â”‚ [â—€ Previous: ICH Protocol]             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

### Card 9B â€“ Rehabilitation Planning (Node FF â†’ HH)
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸƒ REHABILITATION & RECOVERY PLANNING    â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ ğŸ¯ PT/OT assessment priorities:         â”‚
â”‚ â€¢ Baseline functional status           â”‚
â”‚ â€¢ Current mobility limitations         â”‚
â”‚ â€¢ Cognitive assessment                 â”‚
â”‚ â€¢ Safety awareness evaluation          â”‚
â”‚                                         â”‚
â”‚ ğŸ“‹ Intervention planning:               â”‚
â”‚ â€¢ Strength and balance training        â”‚
â”‚ â€¢ Gait training with assistive devices â”‚
â”‚ â€¢ Home safety assessment               â”‚
â”‚ â€¢ Medication education                 â”‚
â”‚                                         â”‚
â”‚ ğŸ  Discharge preparation:               â”‚
â”‚ â€¢ DME (durable medical equipment)      â”‚
â”‚ â€¢ Home health services                 â”‚
â”‚ â€¢ Outpatient therapy referrals         â”‚
â”‚ â€¢ Follow-up appointments               â”‚
â”‚                                         â”‚
â”‚ [Next: Final disposition â–¶]            â”‚
â”‚                                         â”‚
â”‚ [â—€ Previous: Prevention/Monitoring]    â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

### Card 10 â€“ Final Disposition Planning (Node HH - Final)
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ¥ FINAL DISPOSITION & FOLLOW-UP        â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ ğŸ“ Disposition options:                 â”‚
â”‚                                         â”‚
â”‚ ğŸ”´ ICU/Step-down:                       â”‚
â”‚ â€¢ Intracranial hemorrhage monitoring   â”‚
â”‚ â€¢ Post-operative surgical care         â”‚
â”‚ â€¢ Hemodynamic instability              â”‚
â”‚                                         â”‚
â”‚ ğŸŸ¡ Inpatient rehabilitation:             â”‚
â”‚ â€¢ Functional decline                   â”‚
â”‚ â€¢ Multiple comorbidities               â”‚
â”‚ â€¢ Complex medication management        â”‚
â”‚                                         â”‚
â”‚ ğŸŸ¢ Skilled nursing facility:            â”‚
â”‚ â€¢ Intermediate care needs              â”‚
â”‚ â€¢ Short-term rehabilitation            â”‚
â”‚ â€¢ Social support limitations           â”‚
â”‚                                         â”‚
â”‚ ğŸ  Home with services:                  â”‚
â”‚ â€¢ Stable, ambulatory                  â”‚
â”‚ â€¢ Adequate support system              â”‚
â”‚ â€¢ Low fall risk after intervention    â”‚
â”‚                                         â”‚
â”‚ ğŸ“‹ Follow-up coordination:              â”‚
â”‚ â€¢ Primary care: Within 1 week          â”‚
â”‚ â€¢ Orthopedics: 2 weeks if fracture     â”‚
â”‚ â€¢ Neurology: If head injury            â”‚
â”‚ â€¢ PT/OT: Outpatient continuation       â”‚
â”‚                                         â”‚
â”‚ âœ… FALL ASSESSMENT PROTOCOL COMPLETE   â”‚
â”‚                                         â”‚
â”‚ [â—€ Previous: Care Planning]            â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

## VIRTUA VOORHEES FALL ASSESSMENT ADDENDA

### **Enhanced RRT Response Program:**
- **Rapid Response Team:** Immediate multidisciplinary activation including geriatrics, orthopedics, and neurology consultation
- **Fall Prevention Specialists:** Dedicated team of nurses trained in fall risk assessment and intervention
- **Environmental Safety Team:** Real-time assessment and modification of patient rooms
- **Quality Metrics:** Fall rates, injury rates, time to CT for high-risk patients, prevention intervention compliance

### **Updated 2023-2024 Guidelines Integration:**
**AGS 2023 Updated Beers Criteria:**
- **Fall-risk-increasing drugs (FRIDs):** Expanded list including newer medications[51]
- **Deprescribing protocols:** Systematic approach to medication reduction
- **Polypharmacy thresholds:** Refined criteria for intervention (â‰¥5 medications)[25]

**WHO 2023 Global Report Updates:**
- **Multifactorial risk assessment:** Enhanced screening tools
- **Exercise prescription:** Specific balance and strength training protocols
- **Environmental modification:** Evidence-based home safety interventions

### **Advanced Risk Assessment Tools:**
**Morse Fall Scale (2024 Validation):**
- **Score 0-24:** Low risk (6% fall rate)
- **Score 25-50:** Moderate risk (13% fall rate)  
- **Score â‰¥51:** High risk (78% fall rate)
- **Dynamic scoring:** Real-time updates based on condition changes

**STRATIFY Tool Integration:**
- **Presents with confusion:** 2 points
- **On medication affecting cognition:** 2 points
- **Visual impairment:** 1 point
- **Toileting frequency:** 2 points
- **Transfer/mobility issues:** 2 points

### **Anticoagulation Reversal Protocols (Updated 2024):**
**Warfarin Reversal:**
- **4-Factor PCC (Kcentra):** 25 units/kg for INR 2-4, 35 units/kg for INR 4-6
- **Vitamin K:** 10mg IV (effects in 6-24 hours)
- **Target INR:** <1.4 within 30 minutes for urgent procedures

**DOAC Reversal:**
- **Idarucizumab (Praxbind):** 5g IV for dabigatran reversal
- **Andexanet alfa:** For factor Xa inhibitors (apixaban, rivaroxaban)
- **4-Factor PCC:** 25-50 units/kg if specific antidotes unavailable

### **Imaging Decision Support:**
**Canadian CT Head Rule (2023 Validation):**
- **Sensitivity:** 99.4% for clinically important brain injury
- **Specificity:** 50.6% (reduces unnecessary CTs)
- **NPV:** 99.98% when rule negative

**Updated Indications for CT:**
- **Age â‰¥65 years** with any head strike
- **Anticoagulation** regardless of mechanism
- **GCS <15** at 2 hours post-injury
- **Dangerous mechanism:** Height >3 feet or stairs

### **Fall Prevention Technology Integration:**
**Bed Alarm Systems:**
- **Weight-sensitive alarms:** Detect patient movement
- **Video monitoring:** AI-powered fall detection
- **Wearable sensors:** Real-time movement analysis
- **Smart room technology:** Environmental hazard detection

**Electronic Health Record Integration:**
- **Automated risk scoring:** Real-time Morse scale calculation
- **Medication alerts:** FRIDs identification and warnings
- **Order sets:** Standardized fall prevention interventions
- **Analytics dashboard:** Unit-level fall metrics and trends

### **Medication Management Protocols:**
**High-Risk Medication Review:**
- **Benzodiazepines:** Taper schedule over 2-4 weeks
- **Antipsychotics:** Discontinue if used for sleep/behavior
- **Sedative-hypnotics:** Non-pharmacologic sleep interventions
- **Opioids:** Multimodal pain management alternatives

**Polypharmacy Optimization:**
- **Medication reconciliation:** Within 24 hours of admission
- **Pharmacy consultation:** For patients on â‰¥10 medications
- **Deprescribing protocols:** Evidence-based reduction strategies
- **Patient education:** Understanding fall risk medications

### **Multidisciplinary Team Integration:**
**Pharmacy Services:**
- **24/7 availability:** For anticoagulation reversal guidance
- **Medication optimization:** Fall risk medication review
- **Deprescribing consultation:** Systematic medication reduction

**Physical/Occupational Therapy:**
- **Immediate assessment:** Within 24 hours of fall
- **Balance training:** Evidence-based exercise protocols
- **Assistive device evaluation:** Walker, cane fitting
- **Home safety assessment:** Environmental modification recommendations

### **Quality Improvement Metrics:**
**Process Measures:**
- **Fall risk assessment completion:** >95% within 4 hours of admission
- **High-risk intervention implementation:** >90% within 8 hours
- **CT completion time:** <2 hours for Canadian CT Rule positive
- **Anticoagulation reversal time:** <30 minutes for ICH

**Outcome Measures:**
- **Fall rates:** Target <3.5 per 1000 patient days
- **Fall-related injuries:** Target <1.5 per 1000 patient days
- **Appropriate CT utilization:** Adherence to decision rules >85%
- **Anticoagulation reversal success:** Target INR <1.4 in 90% within 30 min

### **Special Population Considerations:**
**Elderly Patients (â‰¥75 years):**
- **Lower threshold for imaging:** Age alone increases risk
- **Frailty assessment:** Clinical Frailty Scale integration
- **Goals of care:** Discussion of comfort vs aggressive intervention

**Patients with Dementia:**
- **Modified assessment tools:** Appropriate for cognitive impairment
- **Behavioral interventions:** Non-pharmacologic agitation management
- **Family involvement:** Caregiver education and support

**Anticoagulated Patients:**
- **Immediate CT imaging:** No delay for clinical observation
- **Reversal preparation:** Automatic pharmacy notification
- **Hematology consultation:** Complex anticoagulation decisions

### **Integration with Other Protocols:**
- **Altered Mental Status:** For patients with confusion after falls
- **Shock Protocol:** For hemodynamically unstable patients
- **RSI Protocol:** If airway protection needed
- **Code Blue:** For cardiac arrest secondary to trauma

### **Discharge Planning & Follow-up:**
**Home Safety Assessment:**
- **Environmental hazards:** Throw rugs, poor lighting, stairs
- **Bathroom modifications:** Grab bars, raised toilet seats
- **Medication management:** Pill organizers, timing optimization
- **Emergency planning:** Medical alert systems

**Outpatient Follow-up:**
- **Primary care:** Within 1 week for medication review
- **Fall prevention clinic:** Specialized multidisciplinary evaluation
- **Physical therapy:** Outpatient balance and strength training
- **Ophthalmology:** Vision screening and correction

### **Patient and Family Education:**
**Fall Prevention Education:**
- **Risk factor modification:** Medication adherence, vision correction
- **Exercise programs:** Home-based balance and strength training
- **Environmental safety:** Home modification recommendations
- **When to seek help:** Warning signs requiring emergency care

**Caregiver Training:**
- **Safe transfer techniques:** Proper body mechanics
- **Mobility assistance:** Walker and cane usage
- **Emergency response:** What to do if fall occurs
- **Medication management:** Understanding fall risk medications

## REFERENCE GUIDELINES
- **2023 American Geriatrics Society Updated Beers Criteria**
- **2024 NICE Quality Standard for Falls Prevention in Older People**
- **2023 WHO Global Report on Falls Prevention in Older Age**
- **Canadian CT Head Rule (2023 Validation Studies)**
- **Virtua Health System Fall Prevention Protocol v2025**

**This comprehensive protocol integrates current evidence-based fall assessment and prevention strategies with advanced risk stratification, rapid imaging decision-making, and comprehensive multidisciplinary care optimized for excellent patient safety outcomes at Virtua Voorhees.**
